» Articles » PMID: 15901850

Expression Profiling of ABC Transporters in a Drug-resistant Breast Cancer Cell Line Using AmpArray

Overview
Journal Mol Pharmacol
Date 2005 May 20
PMID 15901850
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

ATP-binding cassette (ABC) membrane proteins comprise a superfamily of transporters with a wide variety of substrates. Humans have 49 members in this superfamily. Several human ABC transporters, such as ABCB1 and ABCC1, have been attributed to cause multidrug resistance (MDR) in cancer treatment when over-expressed. In the past, an MDR cancer cell line MCF7/AdVp3000 has been selected, and overexpression of ABCG2 was thought to cause MDR in this cell line. However, ectopic overexpression of ABCG2 in MCF7 cells could not explain the high drug resistance level observed with the selected cell line. In this study, we designed an AmpArray analysis to profile whether other ABC transporters were also selected to contribute to the increased drug resistance in MCF7/AdVp3000 cells. We found that 16 ABC transporters, including ABCG2, had >/=1.5-fold altered expression in MCF7/AdVp3000 compared with the parental MCF7 cells. In particular, the expression of ABCA4 and ABCC3 was increased by 132- and 459-fold, respectively, whereas ABCG2 was increased by approximately 3000-fold. Furthermore, the elevated expression of these three transporters reversed with the reversed drug resistance phenotype, and silencing ABCC3 expression in MCF7/AdVp3000 cells significantly reduced doxorubicin resistance. Thus, other ABC transporters in addition to ABCG2 are likely to contribute to the MDR selected in MCF7/AdVp3000 cells. This study also shows that AmpArray can be used as a quick and easy tool to profile the expression of ABC transporters in resistant cell lines and tumor samples for potential use in individualized design of therapy.

Citing Articles

Upregulation of USP22 and ABCC1 during Sorafenib Treatment of Hepatocellular Carcinoma Contribute to Development of Resistance.

Chang Y, Su C, Chen S, Chen Y, Liang Y, Wu J Cells. 2022; 11(4).

PMID: 35203285 PMC: 8870465. DOI: 10.3390/cells11040634.


Quantitative site- and structure-specific N-glycoproteomics characterization of differential N-glycosylation in MCF-7/ADR cancer stem cells.

Xu F, Wang Y, Xiao K, Hu Y, Tian Z, Chen Y Clin Proteomics. 2020; 17:3.

PMID: 32042278 PMC: 7001331. DOI: 10.1186/s12014-020-9268-7.


MicroRNA-495-3p inhibits multidrug resistance by modulating autophagy through GRP78/mTOR axis in gastric cancer.

Chen S, Wu J, Jiao K, Wu Q, Ma J, Chen D Cell Death Dis. 2018; 9(11):1070.

PMID: 30341283 PMC: 6195618. DOI: 10.1038/s41419-018-0950-x.


Sulbactam-enhanced cytotoxicity of doxorubicin in breast cancer cells.

Wen S, Su S, Liou B, Lin C, Lee K Cancer Cell Int. 2018; 18:128.

PMID: 30202239 PMC: 6123926. DOI: 10.1186/s12935-018-0625-9.


Overcoming transporter-mediated multidrug resistance in cancer: failures and achievements of the last decades.

Paskeviciute M, Petrikaite V Drug Deliv Transl Res. 2018; 9(1):379-393.

PMID: 30194528 DOI: 10.1007/s13346-018-0584-7.